Helathiomics: Translational Studies
Transforming Hope into Cure
Neoantigen Vaccine Program
A personalized vaccine program enabled by CureScience for cancer patients. The vaccine is tailored to the individual's tumor mutations. The neoepitope is predicted based on individual's sequenced data. Based on the predictions, an optimized peptide combination is translated into therapy.